Intuitive Surgical, Inc. $ISRG Shares Bought by Chicago Partners Investment Group LLC

Chicago Partners Investment Group LLC raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 65.0% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,875 shares of the medical equipment provider’s stock after acquiring an additional 2,315 shares during the period. Chicago Partners Investment Group LLC’s holdings in Intuitive Surgical were worth $2,657,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Main Street Group LTD purchased a new position in shares of Intuitive Surgical during the 1st quarter worth about $30,000. North Point Portfolio Managers Corp OH purchased a new stake in Intuitive Surgical in the 3rd quarter worth about $27,000. John Boyer Inc. bought a new stake in Intuitive Surgical in the third quarter worth about $27,000. Compass Wealth Management LLC bought a new stake in Intuitive Surgical in the third quarter worth about $29,000. Finally, Evergreen Advisors LLC purchased a new position in shares of Intuitive Surgical during the first quarter valued at approximately $35,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 3.4%

NASDAQ:ISRG traded down $15.72 during midday trading on Friday, hitting $452.80. The stock had a trading volume of 2,150,343 shares, compared to its average volume of 2,506,658. The stock has a 50-day moving average of $409.93 and a 200 day moving average of $431.89. The company has a market capitalization of $156.96 billion, a price-to-earnings ratio of 54.75, a PEG ratio of 3.01 and a beta of 1.45. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The business had revenue of $3.05 billion during the quarter, compared to analyst estimates of $2.91 billion. During the same period in the previous year, the company posted $2.40 EPS. Intuitive Surgical’s revenue was up 21.7% on a year-over-year basis. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Da Vinci system placements increased 28% year over year to 546 in the third quarter of 2026, and net placements rose 40%, expanding the installed base and supporting future revenue from instruments and services. Article: ISRG System Placements Rise 28%
• Neutral Sentiment: Analysts caution that the placement jump may have been driven partly by multisystem orders and upgrades, so it does not necessarily signal a broad-based increase in hospital capital spending or guarantee the pace will continue. Article: ISRG System Placements Rise 28%: Is Capital Equipment Demand Rising?
• Neutral Sentiment: Recent Zacks coverage says ISRG is attracting investor attention but, in the information provided, identifies no new fundamental development that would explain a change in the stock’s prospects. Article: ISRG is Attracting Investor Attention
• Negative Sentiment: Directors Gary Guthart and Craig Barratt reported sales of 10,000 and 1,150 shares, respectively. Both transactions were made under pre-arranged Rule 10b5-1 plans, which may lessen their signaling significance, but insider selling can still add a modest sentiment headwind. SEC filing: Gary Guthart transaction SEC filing: Craig Barratt transaction

Insider Activity

In related news, Director Amy Ladd sold 400 shares of Intuitive Surgical stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the completion of the sale, the director directly owned 251 shares in the company, valued at $95,129. The trade was a 61.44% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 4,047 shares of the company’s stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $453.21, for a total transaction of $1,834,140.87. Following the completion of the sale, the vice president directly owned 1,026 shares of the company’s stock, valued at approximately $464,993.46. This trade represents a 79.78% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 49,928 shares of company stock valued at $21,917,367. Company insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on ISRG shares. Zacks Research raised Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Thursday, October 22nd. BTIG Research reaffirmed a “buy” rating and issued a $454.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Piper Sandler reiterated an “overweight” rating on shares of Intuitive Surgical in a research note on Friday, August 21st. Leerink Partners set a $503.00 target price on Intuitive Surgical and gave the stock an “outperform” rating in a research report on Wednesday, October 21st. Finally, BNP Paribas Exane raised shares of Intuitive Surgical to an “outperform” rating in a research note on Tuesday, July 28th. One research analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $493.54.

Intuitive Surgical Company Profile